PurAir Tablet 10 mg (Montelukast Sodium)

Adult dose

This medication is taken once daily, with asthma patients taking it in the evening, and allergic rhinitis patients determining the dosage time according to their condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Adults and adolescents aged 15 years and older should take 10 mg montelukast orally once daily.

This medication contains an artificial sweetener called aspartame, which should not be administered to patients with the hereditary disease phenylketonuria. The daily intake of aspartame should be limited to below the WHO recommended amount, and care should be taken not to exceed a maximum of 2.4 g per day for an adult weighing 60 kg. Patients who have allergic reactions to the ingredients in this medication or who have hereditary issues such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medication. This medication is not intended for treating acute asthma attacks, so suitable emergency bronchodilators should be kept and used during asthma exacerbations. While taking this medication, the dosage of inhaled corticosteroids may be gradually reduced according to the doctor's instructions, but sudden changes should be avoided. It should not be used alone for exercise-induced bronchospasm treatment; if necessary, an inhaled β-agonist should be used together. Patients with aspirin hypersensitivity should avoid using aspirin or non-steroidal anti-inflammatory drugs while taking this medication. This medication can occasionally cause serious side effects such as systemic eosinophilia or vasculitis, so doctors should carefully monitor the patient's symptoms. Women who are pregnant or breastfeeding should consult their doctor before taking this medication and should only use it when necessary. Both children and the elderly can use this medication, but appropriate dosages and methods of administration should be followed, taking into consideration the safety and efficacy based on age. In case of overdose, there is no specific antidote, so general supportive treatment and clinical monitoring are required. This medication is sensitive to light, so it should not be opened until just before use, and should be taken within 15 minutes after preparation. Store in a place out of reach of children and avoid transferring to other containers. This medication should be taken consistently even when there are no asthma symptoms, and if symptoms worsen or unusual symptoms appear, consult a doctor immediately.

Serious side effects

Urticaria, angioedema, toxic epidermal necrolysis, Stevens-Johnson syndrome, anaphylaxis, hepatic eosinophilia, liver abnormalities (increased ALT and AST, cholestatic hepatitis, hepatocellular liver damage, mixed liver injury), increased bleeding frequency, suicidal thoughts and behaviors, seizures, pulmonary eosinophilia, systemic eosinophilia, Churg-Strauss syndrome, vasculitis, severe edema

Mild side effects

• Weakness/fatigue
• fever
• abdominal pain
• trauma
• indigestion
• infectious gastroenteritis
• toothache
• dizziness
• headache
• nasal congestion

This medication should be kept in a tightly closed container that protects it from air and moisture. It should also be stored away from direct sunlight, at room temperature between 1 to 30 degrees Celsius to maintain its efficacy and safety.

Appearance

Beige film-coated tablets in a rounded square shape

Package unit

28 tablets (7 tablets/PTP*4)